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We report a 50-year-old womanwith orbital sarcoidosis. The initial presentation was painless swelling in
the upper eyelid and mildly limited extraocular motion. A heterogeneous mass with a surrounding bony
defect was noted on an orbital computerized tomography scan. Histopathological examination revealed
noncaseating granulomas, which were compatible with a diagnosis of sarcoidosis. Elevation of the serum
angiotensin-converting enzyme level and mediastinal lymphadenopathy, found on chest computerized
tomography, also conﬁrmed the diagnosis. The patient was treated with low-dose corticosteroids for
5 weeks and showed a favorable outcome.
Copyright © 2014, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
Sarcoidosis is a multisystem disease of unknown cause, which is
characterized histopathologically by noncaseating granulomas.
Ocular involvement varies with race and sexes, and is seen in
approximately 25% of patients [1]. The most common ocular
manifestation is uveitis [2]; orbital sarcoidosis is uncommon, and a
few series have been reported in the literature [3e5]. We present a
case of orbital sarcoidosis.2. Case Report
A 50-year-old woman presented with painless left eyelid
swelling for 1 month. She had no systemic diseases and no recent
trauma history. On examination, her best-corrected visual acuity
was 20/20 and intraocular pressures were within the normal limits
in both eyes. Slit-lamp and fundus examinations revealed no ab-
normalities. The upper eyelid of the left eye was mildly erythem-
atous and swollen, but not tender. Her extraocular movement
showed a slight limitation of supraduction and abduction (Fig. 1).
Her pupils were isocoric and reacted promptly to light stimuli., Buddhist Tzu Chi General
aiwan. Tel.: þ886 3 8561825;
elief Tzu Chi Foundation. PublishePrednisolone 25 mg/day for 1 week was prescribed as a treatment
trial under the suspicion of an orbital pseudotumor. However,
orbital computerized tomography showed a heterogeneous mass
with a surrounding bony defect (Fig. 2A), which is not commonly
seen in orbital pseudotumors; hence, an incisional biopsy was
performed. The tumor was ﬁrm, with a cartilage-like consistency.
Histopathological ﬁndings were diffuse noncaseating granulomas
consisting of epithelioid histiocytes and Langhans giant cells
(Fig. 3A). Special stains for acid-fast bacilli and fungi were negative
(Fig. 3B and C). Her serum angiotensin-converting enzyme level
was 25.11 units (normal <22.5 units). A chest radiograph revealed
no hilar lymphadenopathy. The patient was reviewed further by a
pulmonologist, and enlargement of mediastinal lymph nodes was
found on chest computerized tomography (Fig. 2B). A diagnosis of
orbital sarcoidosis was made, and she was treated with 10 mg of
prednisolone per day for 1 month. The eyelid swelling and limita-
tion of extraocular motion resolved (Fig. 4). She has been followed
for 6 months without recurrence.
3. Discussion
Orbital soft tissue involvement is a distinctly uncommon
manifestation of sarcoidosis. In one large series of ophthalmic
manifestations of sarcoidosis, orbital involvement was seen in two
of 202 patients (1%) [3]. Analysis in a recent case series demon-
strated that orbital sarcoidosis occurs predominantly in patients
older than 50 years and is more common inwomen [6]. The unique
clinical presentation in our case was the bony defect on thed by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Initial extraocular presentation. Mild redness and swelling are present in the left upper eyelid. Note that the left eye is mildly displaced inferiorly. There are limitations of
upward and left gaze.
Fig. 2. (A) Orbital CT. A left orbital lesion with bony defect is seen on the CT scan
(white arrow). (B) Chest CT. An enlarged mediastinal lymph node is noted (black ar-
row). CT ¼ computerized tomography.
Fig. 4. Clinical picture after steroid treatment. The left eye is in a normal position
without displacement compared with that in Fig. 1. Eyelid swelling has resolved.
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has not been mentioned in previous reports. This image could lead
clinicians to consider the lesion a malignancy, such as adenoid
cystic adenocarcinoma of the lacrimal gland, and a biopsy is
mandatory to conﬁrm the diagnosis. Another distinct point in our
case was the rapid response to low-dose corticosteroids. Oral ste-
roids have been the mainstay of treatment in these patients, and
most reported cases have shown a good response. In cases without
an active systemic disease, a short course of oral prednisolone,
starting at 1 mg per kilogram of body weight and tapering over 3
months, may be considered as an initial therapy for orbital
sarcoidosis [6,7]. In localized orbital disease, periocular injections
of steroids may be an alternative treatment [8]. Other treatmentsFig. 3. (A) Histopathological ﬁndings. Granulomas consisting of epithelioid cells and Langh
toxylineeosin, 400). (B) Negative results of acid-fast stains (400). (C) Negative results oinclude surgical excision of the lesion, or observation alone. In a
case series, the lesions regressed in 43% of patients with orbital
sarcoidosis treated with observation alone, and the response to
excisional biopsy and corticosteroid therapy were 88% and 73%,
respectively [9]. We could not rule out a natural course of sponta-
neous regression in our case, and it could be the reason why she
had a good response even to low-dose, short-duration corticoste-
roid treatment. Further large-scale studies are necessary to provide
sufﬁcient data on the natural history and standard treatment of
orbital and adnexal sarcoidosis.References
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